Diabetic Peripheral Neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who are diagnosed as Type1 or Type2 diabetes and have numbness/pain in the extremities. 2) Obtaining written informed consent. 3) No severe disfunction in the: liver, kidney, respiration and hematopoietic system.
Exclusion criteria
Exclusion criteria: 1) Patient who have any one of the following conditions; # neuropathic disorder such as sciatica # symptoms considered to be related with peripheral entrapment neuropathy such as tarsal tunnel syndrome. # Sensory disturbance related with cerebrovascular disease. # Disturbance in the peripheral circulation such as Raynaud's disease or arteriosclerosis obliterans (ASO). 2) Severely uncontrolled blood glucocse (HbA1c=>10%). 3) Currntly pregnant or possibility of pregnancy. 4) Psychiatric disordes or any kind of cognitive dysfunctions that make understanding of the participation to the trial difficult. 5) Other conditions that are not considered eligible by the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of numbness/pain in the extremities which was evaluated with a visual analog scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of the symptom with a faces scale, McGill-Melzack Pain Questionnaire (MPQ), SF-36 (QOL), Profile of mood status (POMS), Nerve conduction velocity, sensory threshold (Semmes-Weinstein Monofilament test), Autonomic nerve function, Vibratory sensation threshold. | — |
Countries
Japan
Contacts
Osaka University Graduate School of Medicine Department of Complementary and Alternative Medicine